Angiotensin-converting enzyme 2 (ACE2) is the entry receptor for severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), the cause of Coronavirus Disease-2019 (COVID …

The COVID-19 pandemic is caused by the severe acute-respiratory-syndrome-coronavirus-2
that uses ACE2 as its receptor. Drugs that raise serum/tissue ACE2 levels include ACE …

Since the beginning of the twenty-first century, epidemic outbreaks of deadly pneumonia
have been caused by three coronaviruses: severe acute respiratory syndrome (SARS) …

Abstract SARS-CoV-2, the agent of COVID-19, shares a lineage with SARS-CoV-1, and a
common fatal pulmonary profile but with striking differences in presentation, clinical course …

Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …

The initial reports on the epidemiology of coronavirus disease 2019 (COVID-19) emanating
from Wuhan, China, offered an ominous forewarning of the risks of severe complications in …

Although clinical manifestations of the 2019 novel coronavirus disease pandemic (COVID-
19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) …

A new type of pneumonia caused by a novel coronavirus SARS-CoV-2 outbreaks recently in
China and spreads into many other countries. This disease, named as COVID-19, is similar …

SARS-CoV-2 is characterized by a spike protein allowing viral binding to the angiotensin-
converting enzyme (ACE)-2, which acts as a viral receptor and is expressed on the surface …

Since angiotensin converting enzyme 2 (ACE2) was identified as the host receptor for
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), speculation has arisen …